The pharmaceutical, biotechnology and healthcare industry already had stringent processes and regulations in place to protect patient data, and have long been aware of the importance of Data Protection, so is there really anything to be concerned about?
Yes. There are some key changes in the new data protection legislation that will impact Life Science organisations and requires attention. GDPR entails increased documentation on processing activities, classifies pseudonymised data as personal data and widens the countries in scope.
This highlights just a few of the requirements set out in the 99 articles of the GDPR. Ignoring the need to change in order to meet these new requirements could result in large fines and penalties.
Our team of expert data consultants and Data Privacy Officers have the deep knowledge around data protection legalisation and can guide your organisation through the steps required to ensure you are compliant.
We have also invested significant effort to examine the specific impact of the legislation on the Life Science Industry, and are supporting Sponsors, CROs and associated businesses with industry-specific advice and services.